1. Ahmad A., Moriguchi T., and Salem N. J.-(2002). Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr. Neurol. 26:210–218.
2. Akbar M., Calderon F., Wen Z. M., and Kim H. Y. (2005). Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl Acad. Sci. USA 102:10858–10863.
3. Akbar M. and Kim H. Y. (2002). Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J.-Neurochem. 82:655–665.
4. Aniksztejn L. and Ben Ari Y. (1991). Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus. Nature 349:67–69.
5. Ariel A., Li P. L., Wang W., Tang W. X., Hong S., Gotlinger K. H., and Serhan C. N. (2005). The novel docosatriene, Protectin D1, produced by TH2-polarization promotes human T cell apoptosis via lipid-raft clustering. Clin. Immunol. 115:S263.